The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fine tuning metabolism of biochemically active abiraterone metabolites to optimize anti-androgen therapy in prostate cancer.
 
Nima Sharifi
Consulting or Advisory Role - Astellas Pharma; Sanofi
 
Zhenfei Li
No Relationships to Disclose
 
Mohammad Alyamani
No Relationships to Disclose
 
Jianneng Li
No Relationships to Disclose
 
Sunil Upadhyay
No Relationships to Disclose
 
Steven P. Balk
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Bayer; Dendreon; Janssen-Ortho; Medivation; Tokai Pharmaceuticals
Consulting or Advisory Role - Bayer; Best Doctors, Inc; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen-Ortho; Medivation; Sanofi; Tokai Pharmaceuticals; UpToDate
Research Funding - Bayer; Genentech; Janssen-Ortho; Medivation
Travel, Accommodations, Expenses - Dendreon; Janssen Oncology; Medivation; Tokai Pharmaceuticals
 
Richard J. Auchus
Stock and Other Ownership Interests - Johnson & Johnson (I)
Consulting or Advisory Role - Biomarin; Bluebird Bio; Concept Pharmaceuticals; Ipsen; Isis Pharmaceuticals; Janssen; LabCorp; Merck; Novartis; Pfizer; Tokai Pharmaceuticals; Viamet Pharmaceuticals
Research Funding - Neurocrine Biosciences; Novartis; Strongbridge Bio
Travel, Accommodations, Expenses - Neurocrine Biosciences; Novartis; Strongbridge Bio